Published on GHDx (https://ghdx.healthdata.org)

Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women's and Children's Health's ASPIRIN Trial

General Info

Geography 
Democratic Republic of the Congo (COD)
Guatemala (GTM)
India (IND)
Kenya (KEN)
Pakistan (PAK)
Zambia (ZMB)
View all
Coverage type 
Global
Time period covered 
January, 2016 - December, 2019
Data type
Scientific literature
Keywords 
Hemoglobin, Maternal conditions, Neonatal conditions, Risk factors

Citation

Authors 
Jessani, S, Saleem, S, Hoffman, M K, Goudar, S S, Derman, R J, Moore, J L, Garces, A, Figueroa, L, Krebs, N F, Okitawutshu, J, Tshefu, A, Bose, C L, Mwenechanya, M, Chomba, E, Carlo, W A, Das, P K, Patel, A, Hibberd, P L, Esamai, F, Goldenberg, R L
Journal 
BJOG
Pages 
1487-1496
Publication year 
2021
Suggested citation 
Jessani, S, Saleem, S, Hoffman, M K, Goudar, S S, Derman, R J, Moore, J L, Garces, A, Figueroa, L, Krebs, N F, Okitawutshu, J, Tshefu, A, Bose, C L, Mwenechanya, M, Chomba, E, Carlo, W A, Das, P K, Patel, A, Hibberd, P L, Esamai, F, Goldenberg, R L. Association of hemoglobin levels in the first trimester and at 26 to 30 weeks with fetal and neonatal outcomes: A secondary analyses of the Global Network for Women's and Children's Health's ASPIRIN Trial. BJOG. 2021; 128(9): 1487-1496.
Source URL:https://ghdx.healthdata.org/record/association-hemoglobin-levels-first-trimester-and-26-30-weeks-fetal-and-neonatal-outcomes